Home/Filings/4/0001209191-23-059268
4//SEC Filing

Lim Seah H. 4

Accession 0001209191-23-059268

CIK 0000822370other

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 7:44 PM ET

Size

16.0 KB

Accession

0001209191-23-059268

Insider Transaction Report

Form 4
Period: 2022-10-09
Lim Seah H.
Director
Transactions
  • Purchase

    Common stock, $0.001 par value

    2023-08-30$0.15/sh+20,000$3,000176,000 total
  • Purchase

    Common stock, $0.001 par value

    2023-09-05$0.15/sh+1,700$255177,700 total
  • Sale

    Common stock, $0.001 par value

    2023-12-15$0.11/sh6,000$660171,700 total
  • Other

    Common stock, $0.001 par value

    2023-12-15$0.29/sh+4,447,426$1,289,7544,619,126 total
  • Purchase

    Common stock, $0.001 par value

    2023-08-25$0.27/sh+92,100$24,867156,000 total
  • Purchase

    Common stock, $0.001 par value

    2022-10-09$0.11/sh+25,400$2,79463,900 total
  • Other

    Promissory Note due 9/16/2025

    2023-12-15240,0000 total
    Exercise: $0.29Common Stock (240,000 underlying)
Footnotes (4)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.20 to $0.27, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
  • [F2]The shares shown were issued in exchange for principal and accrued interest under the promissory note of the Issuer held by the reporting person referred to in footnote (2), below, which promissory note was surrendered by the reporting person for cancellation.
  • [F3]Promissory Note due 9/16/2025 surrendered for cancellation in exchange for shares of common stock referred to in footnote (1) above.
  • [F4]Represent shares previously issuable upon maturity of the Promissory Note due 9/16/2025.

Issuer

Emmaus Life Sciences, Inc.

CIK 0000822370

Entity typeother

Related Parties

1
  • filerCIK 0001949484

Filing Metadata

Form type
4
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 7:44 PM ET
Size
16.0 KB